Canopy Growth Corp - Asset Resilience Ratio

Latest as of March 2026: 0.45%

Canopy Growth Corp (WEED) has an Asset Resilience Ratio of 0.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Canopy Growth Corp's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CA$5.05 Million
≈ $3.65 Million USD Cash + Short-term Investments

Total Assets

CA$1.12 Billion
≈ $809.27 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2026)

This chart shows how Canopy Growth Corp's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Canopy Growth Corp.

Liquid Assets Composition Over Time

This chart breaks down Canopy Growth Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Canopy Growth Corp (WEED) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CA$0.00 0%
Short-term Investments CA$5.05 Million 0.45%
Total Liquid Assets CA$5.05 Million 0.45%

Asset Resilience Insights

  • Limited Liquidity: Canopy Growth Corp maintains only 0.45% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Canopy Growth Corp Industry Peers by Asset Resilience Ratio

Compare Canopy Growth Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 0.50%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Neuland Laboratories Limited
NSE:NEULANDLAB
Drug Manufacturers - Specialty & Generic 9.65%
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
Drug Manufacturers - Specialty & Generic 1.18%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%

Annual Asset Resilience Ratio for Canopy Growth Corp (2015–2026)

The table below shows the annual Asset Resilience Ratio data for Canopy Growth Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-03-31 0.45% CA$5.05 Million
≈ $3.65 Million
CA$1.12 Billion
≈ $809.27 Million
-1.49pp
2025-03-31 1.94% CA$17.79 Million
≈ $12.87 Million
CA$917.70 Million
≈ $663.85 Million
-5.39pp
2024-03-31 7.33% CA$95.34 Million
≈ $68.97 Million
CA$1.30 Billion
≈ $940.64 Million
-5.79pp
2023-03-31 13.13% CA$320.14 Million
≈ $231.59 Million
CA$2.44 Billion
≈ $1.76 Billion
-2.92pp
2022-03-31 16.05% CA$900.97 Million
≈ $651.75 Million
CA$5.62 Billion
≈ $4.06 Billion
-11.25pp
2021-03-31 27.30% CA$1.86 Billion
≈ $1.35 Billion
CA$6.82 Billion
≈ $4.94 Billion
+8.39pp
2020-03-31 18.91% CA$1.30 Billion
≈ $938.17 Million
CA$6.86 Billion
≈ $4.96 Billion
-13.62pp
2019-03-31 32.53% CA$2.84 Billion
≈ $2.05 Billion
CA$8.73 Billion
≈ $6.32 Billion
+32.48pp
2018-03-31 0.05% CA$664.00K
≈ $480.33K
CA$1.44 Billion
≈ $1.04 Billion
-12.51pp
2017-03-31 12.56% CA$85.10 Million
≈ $61.56 Million
CA$677.61 Million
≈ $490.17 Million
+12.52pp
2015-03-31 0.04% CA$10.00K
≈ $7.23K
CA$25.96 Million
≈ $18.78 Million
--
pp = percentage points

About Canopy Growth Corp

TO:WEED Canada Drug Manufacturers - Specialty & Generic
Market Cap
$393.94 Million
CA$544.58 Million CAD
Market Cap Rank
#13524 Global
#397 in Canada
Share Price
CA$1.29
Change (1 day)
-2.27%
52-Week Range
CA$1.20 - CA$2.65
All Time High
CA$737.50
About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and … Read more